Slow Release Melatonin
Natural health product licensed in Canada
- Other names
- Dream - Insomnia Relief, Insomnia Relief, Insomnia Relief Ad, Mild Insomnia Relief, Occasional Insomnia Relief, Slow Release Melatonin 3 mg
- Licence holder
- Life Choice Ltd.
- NPN or DIN-HM
- 80079772
- Status
- Active licence
- Licence date
- 30 August 2017
- Revision date
- 22 March 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 3 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Dispersion de copolymère d'ammonio méthacrylate, Lactose monohydraté, Hydrogénophosphate de calcium dihydraté
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 day |
| Adultes | minimum: 55 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Used to promote sleep in adults aged 55 years and older suffering from mild to moderate insomnia. Helps to stabilize sleep-wake cycle (aspect of the circadian rhythm). Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. If symptoms persist continuously for more than 4 weeks (chronic insomnia), consult a health care practitioner as prolonged sleeplessness can be detrimental to one's health. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders.
- Effets indésirables connus
Rare allergic reactions have been known to occur in which case, discontinue use. Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
Source
Official Health Canada record, licence 80079772
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging